申请人:Milbank Jared Bruce John
公开号:US20110112100A1
公开(公告)日:2011-05-12
The present invention relates to compounds of the formula (I)
and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HCV replication.
本发明涉及式(I)化合物及其药学上可接受的盐,含有这种化合物的组合物以及将这种化合物用作HCV复制抑制剂的用途。